NR2F6 promotes the malignant progression of neuroblastoma as an indicator of poor prognosis
PLOS One · 27.05.2025 · 20 (5) · e0324334
DOI: 10.1371/journal.pone.0324334 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 27.05.2025. Verfasst von Yimeng Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministr…. Hauptthemen laut MEDLINE: Neuroblastoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chongqing Science and Technology Commission, Chongqing Municipal Science and Technology Bureau.
Abstract (Originalsprache)
Background
NR2F6 is an orphan nuclear receptor with dual tumorigenic activity in the immune system and tumor cells, playing an essential role in tumor differentiation and immunity. This study aimed to investigate the expression level of NR2F6 in various tumors and its effect on neuroblastoma (NB).
Methods
We evaluated the role of NR2F6 in the genesis and development of 34 different tumors through multiple databases. In addition, we investigated the effects of NR2F6 expression levels on NB risk factors and prognosis using pathology sections and clinical data from primary retroperitoneal NB in children. The effects on cell proliferation, invasion, and migration were explored by knocking down NR2F6 expression in SK-N-BE(2) and SK-N-SH cells.
Results
The findings showed that NR2F6 was significantly correlated with the prognosis of NB and was an important indicator suggesting disease regression. In addition, NR2F6 knockdown slowed down NB cells’ proliferation, invasion, and migration ability in vitro.
Conclusion
Our results suggest that NR2F6 plays a crucial role in tumor-promoting effects and can be used as a potential prognostic marker for NB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Urology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chon…
- Chongqing Key Laboratory of Children Urogenital Development and Tissue Engineering, Chongqing, P.R China.
- Department of pediatrics, The Second Clinical College of Chongqing Medical University: The Second Affiliated Hospital of Chongqing Medical University, Chongqing, P.R China.
ORCID-Profile: Dawei He
Förderung
- Chongqing Science and Technology Commission
- Chongqing Municipal Science and Technology Bureau
Zitieren
APA
Liu, Y., Zhang, Z., Mi, T., Jin, L., Wang, Z., Li, M., Wang, J., Wu, X., Luo, J., Liu, J., Ren, C., & He, D. (2025). NR2F6 promotes the malignant progression of neuroblastoma as an indicator of poor prognosis. PLOS One, 20(5), e0324334. https://doi.org/10.1371/journal.pone.0324334
Vancouver
Liu Y, Zhang Z, Mi T, Jin L, Wang Z, Li M, et al. NR2F6 promotes the malignant progression of neuroblastoma as an indicator of poor prognosis. PLOS One. 2025;20(5):e0324334. doi:10.1371/journal.pone.0324334
BibTeX
@article{Liu2025,
author = {Liu, Yimeng and Zhang, Zhaoxia and Mi, Tao and Jin, Liming and Wang, Zhaoying and Li, Mujie and Wang, Jinkui and Wu, Xin and Luo, Junyi and Liu, Jiayan and Ren, Chunnian and He, Dawei},
title = {NR2F6 promotes the malignant progression of neuroblastoma as an indicator of poor prognosis},
journal = {PLOS One},
year = {2025},
volume = {20},
number = {5},
pages = {e0324334},
doi = {10.1371/journal.pone.0324334}
}
EUVIMED